Spaya is developed by Iktos, a technology leader in AI applied to de novo drug design that has been active since 2016. Building on our experience in the field, we have identified synthetic accessibility and data-driven retrosynthetic analysis as a significant need of medicinal and synthetic chemists. Hence, we decided to embark on this journey and Spaya is the result of our endeavors.
What's the story behind Spaya?
Not yet followed by anyone